Skip to content
MarketScale
‹ Back to IndustriesSciences

‘Everything Everywhere All At Once’ Reminds Scientists and Metaphysicians That Researching the Multiverse Has Important Thematic Fundamentals

The multiverse theory has been the subject of scientific research and philosophical debate for decades. It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties. Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Everything Everywhere All at OnceExistenceFilmMetaphysics
Share

Key takeaways

01

The multiverse theory has been the subject of scientific research and philosophical debate for decades.

02

It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties.

03

Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

The multiverse theory has been the subject of scientific research and philosophical debate for decades. It is a theory that suggests the existence of multiple universes beyond our own, each with its own unique physical laws and properties. Along with the recent phase of the Marvel Cinematic Universe, 2023’s Best Picture-winning film Everything Everywhere All At Once has brought this concept to a wider audience and reignited discussions about the nature of the multiverse. Where do the preeminent experts in this field, both scientists and metaphysicians, land in their current research and understanding of the multiverse?

While the multiverse theory is often discussed within the context of science and physics, it has also been explored within religious and spiritual traditions. Some religions, such as Hinduism and Buddhism, propose the existence of multiple realms or planes of existence beyond our own. These realms may be inhabited by deities, spirits, or other beings.

There are also scientific studies that suggest the multiverse theory may have implications for the nature of consciousness and reality itself. Some physicists have suggested that the existence of multiple universes could help explain the concept of quantum entanglement, where particles appear to be connected in ways that cannot be explained by traditional physics.

While multiverse theory is still a subject of debate and speculation, its exploration continues to provide insights into the nature of the universe and our place within it. As physicians and the larger scientific community continue to posit new perspectives and assessments as to the validity of the theory, there may be some more esoteric fundamentals that can widen the science community’s foundations for why exploring the multiverse is so fascinating and important to begin with. Mike Mantic, co-founder of personal consciousness exploration company Pathfinders, offers his insights on the thematic throughlines present in Everything Everywhere All At Once, and why they’re so important to understanding and researching the metaphysical nature of the multiverse.

Mike’s Thoughts:

“As a shamanic and older states of consciousness practitioner, I’m a strong supporter in the primacy of lived experience and the power of our consciousness. This movie picked up on some major clues quantum physics has given us about the nature of existence, but I find those potentials are best explored and unraveled through consciousness exploration. In this space, we can explore the universes that branch off and the choices we make, even meet those other aspects of ourselves to see where those choices may have taken us. More importantly, we can use consciousness exploration to see how we show up in the universe as multi-dimensional beings, which goes beyond the scope of this movie, and tap into the knowledge, wisdom and ability that those other aspects of ourselves have developed in order to, as it says in the movie itself, live up to your ultimate potential.

So, these connections and explorations can provide unparalleled insight into who we are, fully expressed as that ultimate potential, and provide a guiding light for other consciousness explorers to expand their true nature and purpose, far beyond who we currently understand ourselves to be in this world. I’ve found that this level of consciousness exploration can give us a deeper understanding of how the universe is and the opportunity to explore new concepts, ideas, and possibilities that could potentially lead us as individuals and as a species into a more advanced future.

Now, the movie picks up on these themes, particularly alternate realities that come from the specific choices that we make in our lives, and that sort of splitting off of the universe into alternate realities. However, I reckon it could go so much further. I don’t think it’s quantum physics that’s going to come through with the answers for us as a species. I think it’s exploring our own consciousness and making changes internally.”

Article written by Sonia Gossai.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512